875658-15-4

Upstream product

• 1096130-98-1 C₁₁H₁₃N₃O₃S 
• 113934-31-9 1-(4-methylphenyl)-1H-[1,2,3]-triazol-4-yl carboxylic acid 
• 227959-99-1 methyl 1-(4-methylphenyl)-1H-1,2,3-triazole-4-carboxylate 
• 2101-86-2 p-methylazidobenzene 
• 106-49-0 p-toluidine 

Downstream Products

• 1096130-33-4 C₂₃H₁₈FN₅ 

Relevant academic research and scientific papers

Design, synthesis and antibacterial evaluation of novel 15-membered 11a-azahomoclarithromycin derivatives with the 1, 2, 3-triazole side chain

Macrolides are widely prescribed in clinic to treat various respiratory tract infections. However, due to their inappropriate use, the prevalence of macrolide-resistant strains among clinical isolates has become a concern for public health. Therefore, nov

6-substituted-1-((1-substituted phenyl-1,2,3-triazole-4-yl)methyl)-4-carbonylquinoline-3-ethyl formate compound, and preparation and application thereof

The invention specifically discloses a 6-substituted-1-((1-substituted phenyl-1,2,3-triazole-4-yl)methyl)-4-carbonylquinoline-3-ethyl formate compound, and preparation and application thereof, belonging to the technical field of organic synthesis. The com

Clubbed [1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis

A Novel Clubbed [1,2,3] triazoles with fluorine benzimidazole series of H37Rv strain inhibitors, potentially useful for the treatment of tuberculosis is disclosed on the basis of promising results of preliminary antimicrobial study. Evaluation of the SAR

PYRAZOLE DERIVATIVES

A compound represented by the general formula (I), which is useful as a peroxisome proliferator-activated receptor α/γ agonist, a salt of the compound, and a solvate of either. (In the formula, X, Y, and Z each represents nitrogen or carbon; m is an integ